New guidelines for mental illness turn shyness in children from a personality trait into a mental disorder that warrants drug treatment. Drug companies already target children, who fidget too much in class or have trouble concentrating on their homework, with stimulant drugs for treating attention deficit disorder. Now children who sit too quietly or are more withdrawn than their peers will also be targeted with medication for social anxiety disorder or depression.
The American Psychiatric Association is under fire today by an independent health news site’s launch of the “Disease Mongering Engine” – an online tool that allows users to instantly generate disorders, dysfunctions and syndromes that sound real, but aren’t. Available at www.NewsTarget.com, the Disease Mongering Engine was created by Mike Adams, a vocal critic of modern psychiatric medicine and its practice of labeling healthy people with fictitious diseases, then over-medicating them with patented pharmaceuticals.
“Modern psychiatry has lost its way and has now become a marketing branch of Big Pharma,” Adams said. “Convincing healthy people that they’re diseased, then harming them with unsafe chemical medications, is not a legitimate approach to health and healing.” Diseases ranging from ADHD to Social Anxiety Disorder were “invented” by drug companies and psychiatrists, Adams says, as a way to generate billions of dollars in profits by selling treatment drugs and services to people who don’t need them.
The Citizens Commission on Human Rights, (CCHR) has launched a new video to expose the hypocracy of the pharmaceutically driven campaign to “Stop the Stigma” of mental illness. With its seemingly altruistic sounding agenda to eliminate “stigma” the fact is the real “stigmatization” is coming from those behind this campaign—pharma, psychiatry and pharma-funded front groups such as NAMI and CHADD to name but a few.
With a seemingly altruistic agenda, the fact is the campaign to end the “stigma” of mental illness is one driven and funded by pharma, psychiatry and pharmaceutical front groups such as NAMI and CHADD to name but a few. For example, take NAMI’s campaign to stop the “stigma” and “end discrimination” against the mentally ill—the “Founding Sponsors” were Abbott Labs, Bristol-Myers Squibb, Eli Lilly, Janssen, Pfizer, Novartis, SmithKline Beecham and Wyeth-Ayerst Labs.
With drafts of the latest edition of the world’s leading psychiatry manual emerging, critics question the growing medicalisation of life’s problems. Over the past three decades, unhappiness has been redefined as depression, shyness has been reclassified as social anxiety disorder – even trivial complaints such as fussy eating are now being viewed through a psychiatric prism. Some of this is due to a single book, the Diagnostic and Statistical Manual , which critics claim is contributing to the ever-expanding empire of mental health. The next official edition of the DSM will be published in May 2013, but draft versions are currently doing the rounds.